Serum homocysteine level and protein intake are related to risk of microalbuminuria: The hoorn study

Kidney International

Volumn 54, Issue 1, 1998, Pages 203-209

  Hoogeveen, Ellen K ^a   Kostense, Pieter J ^b   Jager, Agnes ^b   Heine, Robert J ^b   Jakobs, Cornelis ^b   Bouter, Lex M ^b   Donker, Ab J M ^b   Stehouwer, Coen D A ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b NONE

Author keywords

Albumin; Cardiovascular disease; Diabetes; Hyperhomocysteinemia; Hypertension; NIDDM; Vascular dysfunction

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CARDIOVASCULAR RISK; CREATININE URINE LEVEL; FEMALE; GLUCOSE TOLERANCE TEST; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PREVALENCE; PRIORITY JOURNAL; PROTEIN INTAKE; PROTEIN URINE LEVEL; RISK FACTOR; URINALYSIS;

EID: 0031806922     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ki.4495353     Document Type: Article

References (43)

1. DINNEEN SF, GERSTEIN HC: The association of microalbuminuria and mortality in non-insulin-dependent diabetes mellitus. Arch Intern Med 157:1413-1418, 1997
2. YUDKIN JS, FORREST RD, JACKSON CA: Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet ii:530-533, 1988
3. DECKERT T, FELDT-RASMUSSEN B, BORCH-JOHNSEN K, JENSEN T, KOFOED-ENEVOLDSEN A: Albuminuria reflects widespread vascular damage: The Steno hypothesis. Diabetologia 32:219-226, 1989
4. STEHOUWER CDA, NAUTA JJP, ZELDENRUST GC, HACKENG WHL, DONKER AJM, DEN OTTOLANDER GJH: Urinary albumin excretion, cardiovascular disease, and endothelial dysfunction in non-insulin-dependent diabetes mellitus. Lancet 340:319-323, 1992
5. UELAND PM, REFSUM H, BRATTSTRÖM L: Plasma homocysteine and cardiovascular disease, in Atherosclerotic Cardiovascular Disease, Hemostasis, and Endothelial Function, edited by FRANCIS RB JR, New York, Marcel Dekker Inc., 1992, pp 183-236
6. BOUSHEY CJ, BERESFORD SAA, OMENN GS, MOTULSKY AG: A quantitative assessment of plasma homocysteine as a risk factor for vascular disease. JAMA 274:1049-1057, 1995
7. SELHUB J, JACQUES PF, WILSON PWF, RUSH D, ROSENBERG IH: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270:2693-2698, 1993
8. HOOGEVEEN EK, KOSTENSE PJ, BEKS PJ, MACKAAY AJC, JAKOBS C, BOUTER LM, HEINE RJ, STEHOUWER CDA: Hyperhomocysteinemia is associated with an increased risk of cardiovascular disease, especially in non-insulin-dependent diabetes mellitus: A population-based study. Arterioscler Thromb Vasc Biol 18:133-138, 1998
9. METCALF PA, BAKER JR, SCRAGG RKR, DRYSON E, SCOTT AJ, WILD CJ: Dietary nutrient intakes and slight albuminuria in people at least 40 years old. Clin Chem 39:2191-2198, 1993
10. PEDRINI MT, LEVEY AS, LAU J, CHALMERS TC, WANG PH: The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: A meta-analysis. Ann Intern Med 124:627-632, 1996
11. GUTTORMSEN AB, SCHNEEDE J, FISKERSTRAND T, UELAND PM, REFSUM HM: Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects. J Nutr 124:1934-1941, 1994
12. BEKS PJ, MACKAAY AJC, DE NEELING JND, DE VRIES H, BOUTER LM, HEINE RJ: Peripheral arterial disease in relation to glycaemic level in an elderly Caucasian population: The Hoorn Study. Diabetologia 38:86-96, 1995
13. ROWE DJF, DAWNAY A, WATTS GF: Microalbuminuria in diabetes mellitus: Review and recommendations for the measurement of albumin in urine. Ann Clin Biochem 27:297-312, 1990
14. BENNETT PH, HAFFNER S, KASISKE BL, KEANE WF, MOGENSEN CE, PARVING HH, STEFFES MW, STRIKER GE: Screening and management of microalbuminuria in patients with diabetes mellitus: Recommendations to the Scientific Advisory Board of the National Kidney Foundation from an Ad Hoc Committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am J Kidney Dis 25:107-112, 1995
15. UELAND PM, REFSUM H, STABLER SP, MALINOW MR, ANDERSSON A, ALLEN RH: Total homocysteine in plasma or serum: Methods and clinical applications. Clin Chem 39:1664-1779, 1993
16. UBBINK JB, VERMAAK WJH, BISSBORT S: Rapid high-performance liquid Chromatographic assay for total homocysteine levels in human serum. J Chromatogr 565:441-446, 1991
17. FRIEDEWALD WT, LEVY RT, FREDRICKSON DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502, 1972
18. COCKROFT DW, GAULT MH: Prediction of creatinine clearance from serum creatinine. Nephron 16:31-41, 1976
19. WORLD HEALTH ORGANISATION STUDY GROUP ON DIABETES MELLITUS: Technical Report Series No 727. Geneva, WHO, 1985
20. GROOTENHUIS PA, WESTENBRINK S, SIE CMTL, DE NEELING JND, KOK FJ, BOUTER LM: A semi-quantitative food frequency questionnaire for use in epidemiologic research among the elderly: Validation by comparison with dietary history. J Clin Epidemiol 48:859-868, 1995
21. HULTBERG B, AGARDH E, ANDERSSON A, BRATTSTRÖM, ISAKSSON A, ISRAELSSON B: Increased levels of plasma homocysteine are associated with nephropathy, but not severe retinopathy in type I diabetes mellitus. Scand J Clin Lab Invest 51:277-282, 1991
22. ARNADOTTIR M, HULTBERG B, NILSSON-EHLE P, THYSELL H: The effect of reduced glomerular filtration rate on plasma total homocysteine concentration. Scand J Clin Lab Invest 56:41-46, 1996
23. AGARDH CD, AGARDH E, ANDERSSON A, HULTBERG B: Lack of association between plasma homocysteine levels and microangiopathy in type I diabetes mellitus. Scand J Clin Invest 54:637-641, 1994
24. MUNSHI MN, STONE A, FINK L, FONSECA V: Hyperhomocysteinemia following a methionine load in patients with non-insulin-dependent diabetes mellitus and macrovascular disease. Metabolism 45:133-135, 1996
25. NYGÅRD O, NORDREHAUG JE, REESUM H, UELAND PM, FARSTAD M, VOLLSET SE: Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 337:230-236, 1997
26. REMUZZI G, RUGGENENTI P, BENIGNI A: Understanding the nature of renal disease progression. Kidney Int 51:2-15, 1997
27. BRENNER BM, HOSTETTER TH, HUMES HD: Molecular basis of proteinuria of glomerular origin. N Engl J Med 298:826-833, 1978
28. MADDOX DA, BRENNER BM: Glomerular ultrafiltration, in The Kidney (4th ed), Philadelphia, WB Saunders, 1991, pp 205-244
29. DECKERT T, KOFOED-ENEVOLDSEN A, NÖRGAARD K, BORCH-JOHNSON K, FELDT-RASMUSSEN B, JENSEN T: Microalbuminuria. Diabetes Care 15:1181-1191, 1992
30. TAWAKOL A, TORBJØRN O, GERHARD M, WU JT, CREAGER MA: Hyperhomocyst(e)inemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 95:1119-1121, 1997
31. TSAI JC, PERRELLA MA, YOSHIZUMI M, HSIEH CM, HABER E, SCHLEGEL R, LEE ME: Promotion of vascular smooth muscle cell growth by homocysteine: A link to atherosclerosis. Proc Natl Acad Sci USA 91:6369-6373, 1994
32. LOSCALZO J: The oxidant stress of hyperhomocyst(e)inemia. J Clin Invest 98:5-7, 1996
33. MCHARDY KC, GANN ME, ROSS IS, PEARSON DWM: A simple approach to screening for microalbuminuria in a type 1 (insulin-dependent) diabetic population. Ann Clin Biochem 28:450-455, 1991
34. JOHNSTON J, PATERSON KR, O'REILLY D ST J: Estimating urinary albumin excretion rate of diabetic patients in clinical practice. BMJ 306:493-494, 1993
35. KASISKE BL, KALIL RSN, MA JZ, LIAO M, KEANE WF: Effect of antihypertensive therapy on the kidney in patients with diabetes: A meta-regression analysis. Ann Intern Med 118:129-138, 1993
36. ROTHMAN KJ: Modern Epidemiology: Boston, Little Brown and Co., 1986, pp 77-97
37. GUTTORMSEN AB, UELAND PM, SVARSTAD E, REFSUM H: Kinetic basis of hyperhomocysteinemia in patients with chronic renal failure. Kidney Int 52:495-502, 1997
38. BOSTOM A, LATHROP L: Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes. Kidney Int 52:10-20, 1997
39. SELHUB J, JACQUES PF, WILSON PWF, RUSH D, ROSENBERG IH: Vitamin status and intake as primary determinants of homocysteinemia in an elderly population. JAMA 270:2693-2698, 1993
40. TOELLER M, BUYKEN A, HEITKAMP G, BRÄMSWIG S, MANN J, MILNE R, GRIES FA, KEEN H, THE EURODIAB IDDM COMPLICATIONS STUDY GROUP: Protein intake and urinary albumin excretion rates in the EURODIAB IDDM Complications Study. Diabetologia 40:1219-1226, 1997
41. JAMEEL N, PUGH JA, MITCHELL BD, STERN MP: Dietary protein intake is not correlated with clinical proteinuria in NIDDM. Diabetes Care 15:178-183, 1992
42. SCHAAP GH, BILO HJG, ALFERINK THR, OE PL, DONKER AJM: The effect of a high protein intake on renal function of patients with chronic renal insufficiency. Nephron 47:1-6, 1987
43. KONTFSSIS P, JONES S, DODDS R, TREVISAN R, NOSADINI R, FIORETTO P, BORSATO M, SACERDOTI D, VIBERTI GC: Renal, metabolic and hormonal responses to ingestion of animal and vegetable proteins. Kidney Int 38:136-144, 1990